Literature DB >> 6413415

Renal deposition of alpha interferon in systemic lupus erythematosus.

S Panem, N Ordóñez, J Vilcek.   

Abstract

Earlier studies from several laboratories showed that interferon-alpha (IFN-alpha) is present in the sera of a large percentage of patients with systemic lupus erythematosus (SLE). We now report the detection of IFN-alpha by indirect immunofluorescence in renal sections of three patients with SLE but not in six control kidneys. The immunofluorescence reaction was mediated by three hyperimmune antisera to IFN-alpha raised in three different species, but not by any preimmune serum. The reaction was specifically blocked by absorption of the anti-IFN-alpha sera with purified IFN-alpha made by recombinant DNA techniques or with IFN-alpha isolated from the serum of an SLE patient, but not by bovine serum albumin or human immunoglobulin G. In contrast, antisera to IFN-beta or IFN-gamma did not mediate immunofluorescence. The pattern of IFN-alpha deposition resembled that seen with anti-human immunoglobulin G, suggesting association with immune complexes. Immune complexes were then preparatively eluted from the homogenate of an SLE kidney by treatment with buffer at pH 2.8. Biologically active IFN was found in this eluate and was demonstrated to be IFN-alpha by specific neutralization with IFN antisera. These results extend the specific association of IFN-alpha with SLE.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6413415      PMCID: PMC264567          DOI: 10.1128/iai.42.1.368-373.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Le interferon production by human fibroblasts.

Authors:  T G Hayes; Y K Yip; J Vilcek
Journal:  Virology       Date:  1979-10-30       Impact factor: 3.616

2.  Viral immune complexes in systemic lupus erythematosus: specificity of C-type viral complexes.

Authors:  S Panem; N G Ordóñez; A I Katz; B H Spargo; W H Kirsten
Journal:  Lab Invest       Date:  1978-11       Impact factor: 5.662

3.  Interferon treatment of NZB mice: accelerated progression of autoimmune disease.

Authors:  H Heremans; A Billiau; A Colombatti; J Hilgers; P de Somer
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

4.  Progressive glomerulonephritis in mice treated with interferon preparations at birth.

Authors:  I Gresser; C Maury; M Tovey; L Morel-Maroger; F Pontillon
Journal:  Nature       Date:  1976-09-30       Impact factor: 49.962

5.  Interferons and the immune system.

Authors:  B R Bloom
Journal:  Nature       Date:  1980-04-17       Impact factor: 49.962

6.  Characterization of antibody to C-type virus antigens isolated from immune complexes in kidneys of patients with systemic lupus erythematosus.

Authors:  J T Reynolds; S Panem
Journal:  Lab Invest       Date:  1981-05       Impact factor: 5.662

7.  The probable role of interferon in allergy.

Authors:  S V Skurkovich; E I Eremkina
Journal:  Ann Allergy       Date:  1975-12

8.  Electrophoretically pure mouse interferon inhibits growth, induces liver and kidney lesions, and kills suckling mice.

Authors:  I Gresser; M Aguet; L Morel-Maroger; D Woodrow; F Puvion-Dutilleul; J C Guillon; C Maury
Journal:  Am J Pathol       Date:  1981-03       Impact factor: 4.307

9.  Immune interferon in the circulation of patients with autoimmune disease.

Authors:  J J Hooks; H M Moutsopoulos; S A Geis; N I Stahl; J L Decker; A L Notkins
Journal:  N Engl J Med       Date:  1979-07-05       Impact factor: 91.245

10.  Anti-interferon globulin inhibits the development of glomerulonephritis in mice infected at birth with lymphocytic choriomeningitis virus.

Authors:  J Gresser; L Morel-Maroger; P Verroust; Y Rivière; J C Guillon
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

View more
  3 in total

Review 1.  Expression of the genes of interferons and other cytokines in normal and diseased tissues of man.

Authors:  M G Tovey
Journal:  Experientia       Date:  1989-06-15

Review 2.  Mediators of inflammation and their effect on resident renal cells: implications in lupus nephritis.

Authors:  Susan Yung; Kwok Fan Cheung; Qing Zhang; Tak Mao Chan
Journal:  Clin Dev Immunol       Date:  2013-09-22

Review 3.  Pathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus Erythematosus.

Authors:  Timothy A Gottschalk; Evelyn Tsantikos; Margaret L Hibbs
Journal:  Front Immunol       Date:  2015-10-28       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.